- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02105779
Optimizing Cognitive Remediation Outcomes in Schizophrenia (CAST)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to explicitly and aggressively drive an optimal response to neuroplasticity- based cognitive remediation in schizophrenia in order to maximize treatment response. We will investigate factors that have generally been ignored in computer-based cognitive remediation programs-those related to social cognition-- and will delineate their relationship to motivation, functional outcome, and the neural substrates of reward anticipation and emotion processing. Current research indicates that, unless we fully understand and harness these factors, we will not achieve meaningful treatment gains for individuals with schizophrenia.
Our specific aims are:
- To perform an RCT in which 100 schizophrenia subjects are assigned to either 60 hours of neuroplasticity- based computerized targeted cognitive training (TCT) that focuses exclusively on "cold cognition" (a program which trains early sensory processing, attention, working memory and cognitive control in auditory and visual domains), or to 60 hours of training that combines the TCT program with 20 minutes per day of adaptive computerized social cognition training (SCT) exercises.
- To compare the outcomes of these two groups of subjects on measures of neurocognition, social cognition, motivation, and functional outcome.
- To assess subjects six months after the intervention to determine the durability of training effects.
- To identify changes in brain activation patterns in key neural regions as a result of TCT alone vs. TCT+SCT: during reward anticipation, and during emotion recognition.
The timeliness of this approach is supported by recent evidence demonstrating only weak associations between traditional cognitive remediation approaches and functional outcome in schizophrenia, but a strong, direct relationship between social cognition and functional outcome. Thus we must now examine the clinical, functional, and neural effects of a well-designed state-of-the-art cognitive training program that combines neurocognition with social cognition training.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94121
- San Francisco Veterans Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of schizophrenia or schizoaffective disorder
- Between 18-65 years of age
- Clinically stable
- Fluent in English
Exclusion Criteria:
- Recent hospitalization, in the past 3 months
- History of traumatic brain injury
- Neurological disorders
- Inability to participate in the study soberly
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Targeted Cognitive Training
40 hours of BFP auditory training
|
At present, the TCT exercises consist of three modules: an Auditory Processing Module (40-50 hours of training); a Visual Processing Module (30 hours); a Cognitive Control Module prototype (20 hours).
[Based on the results of our current RCT, Posit Science has revised aspects of the training modules in order to further optimize its effectiveness for treatment of schizophrenia.
In this study, we will use updated versions of the training software: an Auditory Module (30 hours), and a Visual Module (30 hours).
Features from the Cognitive Control module prototype have been expanded and incorporated into these new modules.
|
|
Experimental: Social Cognitive Training
40 hours of auditory training and 10 hours social exercises
|
We developed a systematic approach to basic training in facial emotion identification and discrimination and simple social perception and theory of mind tasks using components drawn from three commercially available software packages: the MicroExpressions Training Tool and The Subtle Expressions Training Tool (METT and SETT), plus the MindReading program.
Training begins with simple emotion identification tasks, and slowly progressed to more difficult tasks that required subjects to discriminate between two subtle emotion expressions, and to correctly interpret the emotional significance of brief social scenes.
A total of 10 hours of training occurred over 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Social Cognition at 6 months
Time Frame: Baseline (Intake)/6 months follow-up after trianing completion
|
Social functioning scale
|
Baseline (Intake)/6 months follow-up after trianing completion
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Fisher M, Nahum M, Howard E, Rowlands A, Brandrett B, Kermott A, Woolley J, Vinogradov S. Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report. Psychiatr Rehabil J. 2017 Mar;40(1):21-32. doi: 10.1037/prj0000244.
- Biagianti B, Fisher M, Neilands TB, Loewy R, Vinogradov S. Engagement with the auditory processing system during targeted auditory cognitive training mediates changes in cognitive outcomes in individuals with schizophrenia. Neuropsychology. 2016 Nov;30(8):998-1008. doi: 10.1037/neu0000311. Epub 2016 Sep 12.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MH082818 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States
-
Bradley LegaRecruiting
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Elazığ Mental Health and Diseases HospitalCompleted
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedSchizophrenia DisorderTurkey (Türkiye)
Clinical Trials on Targeted Cognitive Training
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruitingPTSD | Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Psychosis | Serious Mental IllnessUnited States
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Rush University Medical CenterHarvard Medical School (HMS and HSDM); National Institute of Mental Health... and other collaboratorsCompletedClinical High Risk for PsychosisUnited States
-
AdventHealthNational Institute of Mental Health (NIMH)RecruitingMajor Depressive Disorder | ApathyUnited States
-
Massachusetts General HospitalDeborah Munroe Noonan Memorial Research FundCompleted
-
Massachusetts General HospitalLouis V. Gerstner III Research Scholar AwardCompletedTourette Syndrome | Attention-Deficit/Hyperactivity Disorder
-
University of ZurichUniversity Hospital, ZürichRecruitingParkinson's Disease | Mild Cognitive ImpairmentSwitzerland
-
National Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Peking University First HospitalRecruiting
-
Peking University First HospitalCompleted